Does surgery improve prognosis in patients with small-cell lung carcinoma?

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 3, 2013, Pages 375-380

  Jones, Christopher D ^a   Cummings, Ian G ^a   Shipolini, Alex R ^a   McCormack, David J ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Small cell lung cancer; Surgery

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE CONTROL STUDY; HUMAN; LUNG SMALL CELL CANCER; LUNG SURGERY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BENCHMARKING; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; SMALL CELL LUNG CARCINOMA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874304716     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs475     Document Type: Article

References (11)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interac CardioVasc Thorac Surg 2003;2:405-9.
2. Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oatcelled carcinoma of the bronchus. Lancet 1973;302:63-5.
3. Lad T, Piantadosi S, Thomas P, Payne D, Ruckdeschel J, Giaccone G. A prospective randomized trial to determine the benefit if surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994;106:320S-3S.
4. Karrer K, Ulsperger E. Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. Acta Odontol 1995;34:899-906.
5. Eberhardt W, Stamatis G, Stuschke M, Wilke H, Muller MR, Kolks S et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer stages 1B to 3B: long-term results of a phase II trial. Br J Cancer 1999;81:1206-12.
6. Rostad H, Naalsund A, Jacobsen R, Strand T, Scott H, Strom E et al. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy? Eur J Cardiothorac Surg 2004;26:782-6.
7. Badzio A, Kurowski K, Karnicka-Mlodkowska H, Jassem J. A retrospective study of surgery followed by chemotherapy vs. Non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothoracic Surg 2004;26:183-8.
8. Brock M, Hooker C, Syphard J, Westra W, Li Xu M, Alberg A et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 2005;129:64-72.
9. Lim E, Belcher E, Yoon K, Nicholson A, Goldstraw P. The role of surgery in the treatment of limited disease small cell lung cancer. J Thorac Oncol 2008;3:1267-71.
10. Schreiber D, Rineer J, Weedon J, Vongtama D, Wortham A, Kim A et al. Survival outcomes with the use of surgery in limited-stage small lung cancer. Cancer 2010;116(5):1350-7.
11. National Institute for Health and Clinical Excellence. The Diagnosis and Treatment of Lung Cancer. http://guidance.nice.org.uk/cg121. (April 2011, date last accessed).